Indivumed Therapeutics
Martin Heuseler has extensive work experience in finance and controlling roles. Martin started their career as an Assistant Controller at Beate Uhse AG in July 2006, where they worked until July 2008. Martin then joined FinanceScout24 GmbH as a Junior Controller from August 2008 to February 2012. In December 2010, they joined Sysmex Europe as a Controller and worked there until June 2015. Since July 2015, Martin has been working at Indivumed Group, starting as a Senior Controller and then progressing to the role of Director Controlling from June 2020 to January 2023. Currently, they hold the position of Vice President Finance at Indivumed Group, starting from January 2023.
Martin Heuseler completed their Master of Business Administration (MBA) degree in Geschäftsverwaltung und Leitung, allgemein at HHL Leipzig Graduate School of Management from 2020 to 2022. Prior to that, they obtained a BBA in International Management from Europa-Universität Flensburg from 2002 to 2006. Additional education history regarding the University West is not provided.
Indivumed Therapeutics
1 followers
Twenty years of innovation, but a vision that remains unchanged. Valued for the standardized collection and analysis of tissue samples that has enabled a truly unique multi-omics database, we are on the verge of reshaping what is possible in the field of precision oncology. We have unlocked an understanding of the molecular reality of cancer at an unparalleled level that is now supporting biomarker and target discovery and validation, drug development, and clinical trial performance. We continue striving for a world where precision therapy is possible for each individual cancer patient. To learn more about our mission, visit www.indivumed-therapeutics.com.